Ming Cheng Chang

Chief Executive Officer at EXCELSIOR MEDICAL CO., LTD.

Consumer Services

Distribution Services

Health Technology

Profile

Ming Cheng Chang is currently a Director at Arich Enterprise Co., Ltd., RTS Excelsior Co. Ltd., and PharmaCore Biotech Co., Ltd.
He is also the General Manager at Excelsior Medical Co., Ltd.
and a Doctor at Dynamic Medical Technologies, Inc. Prior to his current roles, he obtained undergraduate degrees from the University of Ottawa and National Taiwan University College of Medicine.

Ming Cheng Chang active positions

Companies	Position	Start
ARICH ENTERPRISE CO., LTD.	Director/Board Member	2015-07-15
EXCELSIOR MEDICAL CO., LTD.	Chief Executive Officer	-
PHARMACORE BIOTECH CO., LTD.	Director/Board Member	2020-08-27
DYNAMIC MEDICAL TECHNOLOGIES INC.	Director/Board Member	-
RTS Excelsior Co. Ltd.	Director/Board Member	-

All active positions of Ming Cheng Chang

Training of Ming Cheng Chang

University of Ottawa	Undergraduate Degree
National Taiwan University College of Medicine	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ming Cheng Chang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	3
EXCELSIOR MEDICAL CO., LTD.	Distribution Services
ARICH ENTERPRISE CO., LTD.	Distribution Services
DYNAMIC MEDICAL TECHNOLOGIES INC.	Health Technology

Private companies	2
RTS Excelsior Co. Ltd.
PharmaCore Biotech Co., Ltd. PharmaCore Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology PharmaCore Biotech Co., Ltd. engages in the development and production of active pharmaceutical ingredients (APIs), including anti-cancer drugs, peptides, and antibiotics. Its business activities include the development and production of private brand products, the provision of customized Contract Research Organisations and Contract Manufacturing Organisations (CRO/CMO) services, and the provision of Pharmaceutical Inspection Co-operation Scheme (PIC/S) and Good Manufacturing Practice (GMP) relative regulatory and submission services. The company was founded on January 8, 2015 and is headquartered in Tainan, Taiwan.	Health Technology